Mark For: ONCOTYPE MAP PAN-CANCER TISSUE® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 90142987 |
Registration Number | 6570604 |
Mark Literal Elements | ONCOTYPE MAP PAN-CANCER TISSUE |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | NEW APPLICATION PROCESSING 2020-08-31 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Sana Hakim |
Attorney Docket Number | 2862081-200 |
2020-08-27 | Application Filed |
2020-08-31 | Location: NEW APPLICATION PROCESSING |
2020-08-31 | Status: Live/Pending |
2020-08-31 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
2020-08-31 | Transaction Date |
2021-11-23 | Trademark Registered |
Party: | Genomic Health, Inc. |
Address | 301 Penobscot Drive Redwood City, CALIFORNIA UNITED STATES 94063 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Application | MULTI | 2020-08-27 |
Drawing | IMAGE/JPEG | 2020-08-27 |
IC 042. US 100 101. G & S: Laboratory research in the field of the field of cancer research and disease classification; Providing laboratory research services in the field of genetic testing, including next-generation sequencing (NGS), namely, cancer biology
IC 044. US 100 101. G & S: Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionals, namely oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Laboratory research in the field of the field of cancer research and disease classification; Providing laboratory research services in the field of genetic testing, including next-generation sequencing (NGS), namely, cancer biology |
D10000 | "MAP" AND "PAN-CANCER TISSUE" |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2020-08-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.